Physician profile
Faisal Uddin
NPI 1750541041
$1,042.00
in general payments reported to CMS, 2019-2025
7 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.62 · 2021: $141 · 2022: $274 · 2023: $203 · 2024: $52.19 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $429.73 | 2021-2025 | |
| La Jolla Pharmaceutical Company | $138.58 | 2019-2025 | Giapreza |
| Astrazeneca Pharmaceuticals LP | $135.00 | 2022 | |
| Merck Sharp & Dohme LLC | $124.29 | 2023 | Recarbrio |
| Abbott Laboratories | $83.56 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Melinta Therapeutics, LLC | $78.65 | 2023 | Vabomere |
| Becton, Dickinson and Company | $52.19 | 2024 | Powerpicc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Uddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.